| Followers | 42 |
| Posts | 1059 |
| Boards Moderated | 0 |
| Alias Born | 02/02/2021 |
Tuesday, March 25, 2025 9:08:30 AM
From muee88 on February 4th.
muee88
Tuesday, February 04, 2025
Post# of 747454
Recent response from the MHRA regarding the status of the DCVax application:
“We understand and support the need for treatments for glioblastomas and are actively working to ensure all medicines filed are safe, effective, and manufactured with appropriate quality standards, and subsequently reach patients as rapidly as possible.
In our role we are responsible for licensing medicines and ensuring that both medicines and medical devices work and are acceptably safe.
As you have already seen, the company has announced that they have submitted their application to us. We are working actively on this application, recognising the impact this medicine could potentially have.
[insert a bunch of link for contacting NWBO]
Finally, please be assured we a progressing this application as rapidly as possible and in collaboration with the company.”
muee88
Tuesday, February 04, 2025
Post# of 747454
Recent response from the MHRA regarding the status of the DCVax application:
“We understand and support the need for treatments for glioblastomas and are actively working to ensure all medicines filed are safe, effective, and manufactured with appropriate quality standards, and subsequently reach patients as rapidly as possible.
In our role we are responsible for licensing medicines and ensuring that both medicines and medical devices work and are acceptably safe.
As you have already seen, the company has announced that they have submitted their application to us. We are working actively on this application, recognising the impact this medicine could potentially have.
[insert a bunch of link for contacting NWBO]
Finally, please be assured we a progressing this application as rapidly as possible and in collaboration with the company.”
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
